Cyprus IP Box Requirements & Substance (2026)

Who can claim the Cyprus IP Box?

Regulation 6 of KDP 336/2016 defines eligible taxpayers as Cyprus residents, Cyprus permanent establishments of non-residents, and foreign permanent establishments subject to tax in Cyprus. The asset may include economic ownership. Eligibility therefore cannot be reduced to incorporation of a Cyprus company.

This guide focuses on companies. Their residence, management, functions and tax position require a separate assessment under current law and any applicable treaty. An individual's potential claim must be examined using the rules and rates that apply to that person; the corporate 3% example does not establish an individual's tax rate.

• Check the taxpayer against regulation 6.
• Establish the relevant ownership and qualifying asset.
• Identify income and expenditure attributable to the asset.
• Assess residence and permanent-establishment issues separately.

What counts as qualifying IP?

Only certain classes of IP qualify. The regime targets IP that results from genuine research and development, which is why marketing-related rights are deliberately excluded.

Marketing rights are excluded. A brand cannot be relabelled as software to qualify. Certain other innovative assets have additional certification and size conditions; check the specific category.

• Patents.
• Copyrighted software.
• Utility models.
• Plant breeders' rights and genetic material.
• Orphan-drug designations.
• Other IP that is non-obvious, useful and novel, and certified as such.
• Not qualifying: trademarks, brands, image rights and other marketing-related IP.

You must fund the R&D: the nexus rule

QE is qualifying R&D, A is acquisition cost and R is related-party R&D. OE = QE + A + R. UE = min(30% × QE, A + R). Nexus = min(1, (QE + UE) / OE), where OE is positive. Use the asset’s relevant historical expenditure; the denominator is not every accounting expense.

Economic and tax-residency substance in Cyprus

Assess tax residence, actual management, functions and any permanent-establishment or treaty issues on the facts. Formal incorporation and a registered address do not settle these questions.

The IP Box regulations do not impose a universal requirement for a majority of Cyprus-resident directors, Cyprus banking or exclusively local developers. Genuine decision-making and reliable evidence remain important. Unrelated overseas R&D is not automatically excluded from qualifying expenditure.

Documentation kept contemporaneously

Regulation 5 requires records by asset. Timesheets, project logs and repositories can support them, but no single template proves eligibility. Retain reliable evidence and document any reconstruction or gap.

• A development history for each asset showing how and when it was created.
• Evidence of who performed the R&D: employees, contractors and their roles.
• Per-asset income and cost tracking, kept separate from other activities.
• Timesheets and project logs linking hours to specific IP.
• Code repositories, commit logs and version histories for software.
• Contracts with contractors and evidence that unrelated-party status is genuine.
• Records retained contemporaneously and available for the statutory period.

Common reasons claims fail

Most failed or reduced claims come down to a handful of recurring problems. Knowing them in advance is the cheapest form of insurance.

Almost all of these are avoidable with planning at the outset, before income starts to flow through the structure.

• Claiming without establishing the taxpayer's eligibility under regulation 6.
• Treating a trademark or brand as qualifying IP.
• Acquiring finished IP or outsourcing R&D to related parties, crushing the nexus ratio.
• Unsupported residence, management or functional assumptions; formal paperwork that does not match actual activity.
• No per-asset cost tracking, so the nexus fraction cannot be evidenced.
• Records assembled after the fact rather than kept contemporaneously.
• Management and control located abroad, undermining Cyprus tax residency.

What the regime is worth in 2026

The IP Box allows 80% of qualifying profit (as scaled by the nexus fraction) to be deducted, leaving only the balance subject to corporation tax. Against the 2026 headline corporate rate, this brings the effective rate on qualifying IP income down to roughly 3%.

That figure is indicative and assumes a full nexus fraction and clean substance. The actual outcome depends on your cost mix, your funding of the R&D and the quality of your documentation, so model it on your own numbers before relying on it.